Skip to main content
. 2012 Jan 12;302(7):G664–G675. doi: 10.1152/ajpgi.00430.2011

Fig. 2.

Fig. 2.

Western blot data showing higher levels of expression of RhoA/ROCK II (A and B), phosphorylation of regulatory binding subunit of myosin light chain phosphatase (p-MYPT1; D), phosphorylated protein kinase C-potentiated inhibitor or phosphoprotein for myosin phosphatase (p-CPI-17; E), and myosin light chain phosphorylation (p-MLC20; F) and decreased expression of MYPT1 (C) in the smooth muscle tissues of the IAS compared with the RSM (*P < 0.05).